{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"61.55","upperLimit":"89.16","value":"77.50"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"40"}],"units":"Participants"}],"dispersionType":"95% Confidence Interval","groups":[{"id":"OG000","title":"VDT: VELCADE, Doxil and Low-dose Thalidomide"}],"paramType":"NUMBER","populationDescription":"Evaluable patients","reportingStatus":"POSTED","timeFrame":"Every 3 months","title":"Overall Response Rate (Complete and Partial)","type":"PRIMARY","unitOfMeasure":"percentage of participants"}